(Alliance News) - Topps Tiles PLC on Tuesday said it outperformed the market, despite reporting lower earnings for the first half of the financial year. Read More
(Alliance News) - Topps Tiles PLC on Wednesday said it plans to close 23 stores in a bid to improve profitability as sales growth stalled in the first half of its financial year. Read More
(Alliance News) - Stock prices in London opened higher on Wednesday, amid a busy schedule for manufacturing PMI releases and amid renewed optimism over the Middle East conflict. Read More
(Alliance News) - Topps Tiles PLC on Wednesday said its revenue growth outperformed the market in the first quarter of the 2026 financial year. Read More
(Alliance News) - Reckitt Benckiser proposes a GBP1.6 billion special dividend, Great Portland Estates buys a long-term central London lease and Topps Tiles reports higher sales. Read More
(Alliance News) - Stock prices in London closed in the green on Thursday, following the Bank of England's decision to cut rates and a hold from the European Central Bank. Read More
(Alliance News) - 4imprint Group PLC on Wednesday said it appointed Topps Tiles PLC Chair Paul Forman to be its new chair from March 16, when Paul Moody will step down from the board. Read More
(Alliance News) - HSBC promotes its interim chair to the permanent position, Smiths Group agrees to sell Smiths Detection at an enterprise value of GBP2.0 billion and Paragon Banking raises its total dividend. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Topps Tiles PLC on Wednesday said it continues to make progress towards its goal of increasing annual sales to GBP365 million, after a year of strong sales growth and strategic progress. Read More
(Alliance News) - Stock prices in London were higher at midday on Wednesday as markets got over a wobble on the shutdown of the US government, while the blue-chip index was pushed higher due to a surge in pharmaceutical firms. Read More